Bart M. de Vries

Amsterdam University Medical Centers

Papers

1

Total Citations

135

H-Index

1

About

Bart M. de Vries is a leading researcher at the intersection of nuclear medicine and artificial intelligence, with a primary focus on advancing prostate cancer diagnostics. His key contributions lie in developing machine learning frameworks for the quantitative analysis of PSMA PET imaging, particularly using the [18F]DCFPyL radiotracer. In his landmark 2020 study, which has garnered 135 citations, de Vries demonstrated that machine learning-based radiomics can non-invasively and objectively stratify risk in primary prostate cancer patients, moving beyond traditional qualitative visual assessments. This work has been pivotal in establishing a new paradigm for precision oncology, where computational analysis of PET metrics can guide clinical decision-making. By integrating advanced data science with molecular imaging, de Vries has opened avenues for more personalized treatment planning, reducing reliance on invasive biopsies. His research continues to shape how quantitative imaging biomarkers are harnessed, making him a key figure in the growing field of AI-driven radiomics for oncological applications.

Research Focus

Key Achievements

1
H-Index
1
Papers
135
Total Citations
135
Avg Citations/Paper
🏆 Most Cited Paper
Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer
135 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Amsterdam University Medical Centers

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago